VidPrevtyn Beta

recombinant protein SARS-CoV-2 spike protein vaccine with adjuvant · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VidPrevtyn Beta, covering 2022-11-10 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine. [NA]

See pricing